(T,G)-A-L
Showing 1 - 25 of >10,000
Retinal Deep PhenotypingTM
Recruiting
- Healthy
-
Waterloo, Ontario, Canada
- +2 more
Jun 16, 2023
Chronic Kidney Disease Requiring Chronic Dialysis Trial in Calgary, Edmonton, Toronto (PROMs Assessment)
Active, not recruiting
- Chronic Kidney Disease Requiring Chronic Dialysis
- PROMs Assessment
-
Calgary, Alberta, Canada
- +2 more
Jan 9, 2023
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Oral Upadacitinib Tablets to Assess Change in Disease Symptoms
Recruiting
- Rheumatoid Arthritis (RA)
-
Edmonton, Alberta, Canada
- +38 more
Jan 17, 2023
FGFR Testing by Either ctDNA Blood Testing or Standard Tumor
Recruiting
- Metastatic Bladder Cancer
- Metastatic Urothelial Carcinoma
- FGFR Testing
-
Calgary, Alberta, Canada
- +6 more
Nov 8, 2023
Recurrence After Emergency Presentation for Allergic REaction
Recruiting
- Anaphylaxis
- Observational
-
Calgary, Alberta, Canada
- +6 more
Nov 1, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Olaparib
- +13 more
-
Edmonton, Alberta, Canada
- +9 more
Jan 9, 2023
COPD Trial in Edmonton (digital Remote Patient Monitoring+BEPR+ (dRPM+), Enhanced Breathe Easy Pulmonary Rehabilitation Program
Recruiting
- Chronic Obstructive Pulmonary Disease
- digital Remote Patient Monitoring+BEPR+ (dRPM+)
- Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)
-
Edmonton, Alberta, CanadaG. F. MacDonald Centre for Lung Health
Oct 5, 2023
Adults With Severe Eosinophilic Asthma on Benralizumab.
Active, not recruiting
- Severe Eosinophilic Asthma
- Survey Administration
-
Calgary, Alberta, Canada
- +19 more
Dec 1, 2022
Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)
Terminated
- Renal Cell Carcinoma
- Nivolumab
- Ipilimumab
-
Saint Louis, Missouri
- +11 more
Dec 15, 2022
Shoulder Osteoarthritis Trial in Edmonton, St. Albert, Ottawa (Reverse Total Shoulder Arthroplasty (RTSA), Total Shoulder
Recruiting
- Shoulder Osteoarthritis
- Reverse Total Shoulder Arthroplasty (RTSA)
- Total Shoulder Arthroplasty (TSA)
-
Edmonton, Alberta, Canada
- +7 more
Jul 14, 2022
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023
The Canadian UnRuptured Endovascular Versus Surgery Trial
Completed
- Intracranial Aneurysms
- Surgical management
- Endovascular management
-
Liège, Belgium
- +5 more
Dec 7, 2022
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Bladder Cancer Trial in Canada (Tranexamic Acid, Placebo)
Completed
- Bladder Cancer
- Tranexamic Acid
- Placebo
-
Edmonton, Alberta, Canada
- +9 more
Oct 3, 2022
Cardiac Sarcoidosis Multi-Center Prospective Cohort
Recruiting
- Cardiac Sarcoidosis
-
Calgary, Alberta, Canada
- +13 more
Jun 6, 2022
Chronic Pain Trial in Canada (iCanCope app and website, Attention control group)
Active, not recruiting
- Chronic Pain
- iCanCope app and website
- Attention control group
-
Calgary, Alberta, Canada
- +9 more
Oct 24, 2022
Local Recurrence Following Breast Conserving Surgery and
Active, not recruiting
- Breast Cancer
-
Calgary, Alberta, Canada
- +26 more
Sep 19, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Gastric Cancer, Gastric Adenocarcinoma, Peritoneal Carcinomatosis Trial in Montréal, Quebec City (Indocyanine green)
Recruiting
- Gastric Cancer
- +3 more
- Indocyanine green
-
Montréal, Quebec, Canada
- +1 more
Jan 8, 2023
Elagolix For the Treatment of Endometriosis in Canada
Completed
- Endometriosis
-
Calgary, Alberta, Canada
- +17 more
Sep 26, 2022
Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)
Terminated
- Immunity, Innate
- Colorectal Cancer
- IVDD for NK cell activity in whole blood
-
Montreal, Quebec, Canada
- +2 more
Jan 30, 2023
Idiopathic Pulmonary Fibrosis Trial in Canada (60% Oxygen, Standard of Care)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 60% Oxygen
- Standard of Care
-
Calgary, Alberta, Canada
- +7 more
May 17, 2022
Osteoarthritis Trial in Canada (ATB-346 low dose, Placebo, ATB-346 mid-dose)
Completed
- Osteoarthritis
- ATB-346 low dose
- +3 more
-
Mission, British Columbia, Canada
- +34 more
Jul 20, 2022